A nitric oxide donor NOC 7 suppresses renal responses induced by norepinephrine and angiotensin II in the NO-depleted denevated rabbit kidney

European Journal of Pharmacology

Volumn 342, Issue 2-3, 1998, Pages 285-289

  Ono, Naoto ^a   Adachi, Yuichiro ^a   Hashimoto, Kazuyuki ^a   Yoshida, Makoto ^a   Suzuki Kusaba, Mizue ^a   Hisa, Hiroaki ^a   Satoh, Susumu ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

(Rabbit); Angiotensin II; Kidney; N( ) nitro L arginine methyl ester (L NAME); Nitric oxide (NO); NOC 7 (1 hydroxy 2 oxo 3 (N methyl 3 aminopropyl) 3 methyl 1 triazene); Norepinephrine

Indexed keywords

1 HYDROXY 2 OXO 3 (N METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; ANGIOTENSIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR; NORADRENALIN; SODIUM ION; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; INTRAARTERIAL DRUG ADMINISTRATION; KIDNEY DENERVATION; KIDNEY TUBULE ABSORPTION; MALE; NATRIURESIS; NONHUMAN; PRIORITY JOURNAL; RABBIT; SODIUM URINE LEVEL;

ANGIOTENSIN II; ANIMALS; DENERVATION; ENZYME INHIBITORS; KIDNEY; KIDNEY FUNCTION TESTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NOREPINEPHRINE; RABBITS; RENAL CIRCULATION; TRIAZENES; VASOCONSTRICTOR AGENTS;

EID: 0032567755     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01565-3     Document Type: Article

References (10)

1. ω-nitro-L-arginine methyl ester and losartan. Eur. J. Pharmacol. 308:1996;165-171.
2. Adachi Y., Hashimoto K., Ono N., Yoshida M., Suzuki-Kusaba M., Hisa H., Satoh S. Renal effects of a nitric oxide donor, NOC 7, in anesthetized rabbits. Eur. J. Pharmacol. 324:1997;223-226.
3. Baylis C., Harton P., Engels K. Endothelial derived relaxing factor controls renal hemodynamics in the normal rat kidney. J. Am. Soc. Nephrol. 1:1990;875-881.
4. Hrabie J.A., Klose J.R., Wink D.A., Keefer L.K. New nitric oxide-releasing zwitterions derived from polyamines. J. Org. Chem. 59:1993;1472-1476.
5. Majid D.S.A., Williams A., Navar L.G. Inhibition of nitric oxide synthesis attenuates pressure-induced natriuretic responses in anesthetized dogs. Am. J. Physiol. 264:1993;F79-F87.
6. G-nitro-L-arginine, a nitric oxide synthase inhibitor. Biol. Pharm. Bull. 18:1995;496-500.
7. Ohishi K., Carmines P.K., Inscho E.W., Navar L.G. EDRF-angiotensin II interactions in rat juxtamedullary afferent and efferent arterioles. Am. J. Physiol. 263:1992;F900-F906.
8. Parakh N., Dobrowolski L., Zou A., Steinhausen M. Nitric oxide modulates angiotensin II- and norepinephrine-dependent vasoconstriction in rat kidney. Am. J. Physiol. 270:1996;R630-R635.
9. Tolins J.P., Palmer R.M.J., Moncada S., Raij L. Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am. J. Physiol. 258:1990;H655-H662.
10. Zhang P., Ohara A., Mashimo T., Sun J., Shibuta S., Takada K., Kosaka H., Terada M., Yoshiya I. Cardiovascular effects of an ultra-short-acting nitric oxide-releasing compound, zwitterionic diamine/NO adduct, in dogs. Circulation. 94:1996;2235-2240.